MARKET

CSBR

CSBR

Champions
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.09
-0.05
-0.65%
Opening 14:11 01/29 EST
OPEN
8.13
PREV CLOSE
8.14
HIGH
8.13
LOW
7.97
VOLUME
21.02K
TURNOVER
--
52 WEEK HIGH
12.80
52 WEEK LOW
4.976
MARKET CAP
93.97M
P/E (TTM)
-94.6944
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CSBR and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CSBR News

  • The Children's Cancer Therapy Development Institute is collaborating with Champions Oncology and The Jackson Laboratory to provide RACE Act/PREA pediatric cancer study plan services
  • ACCESSWIRE.5h ago
  • How to Time the Markets Like an Investing Pro - January 17, 2020
  • Zacks.01/17 14:34
  • Is There An Opportunity With Champions Oncology, Inc.'s (NASDAQ:CSBR) 42% Undervaluation?
  • Simply Wall St..01/13 11:07
  • The Market Timing Secrets No One Talks About - December 24, 2019
  • Zacks.12/24/2019 14:37

More

Industry

Biotechnology & Medical Research
-0.01%
Pharmaceuticals & Medical Research
+0.39%

Hot Stocks

Name
Price
%Change

About CSBR

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans. The TOS segment provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. Its TumorGraft Technology Platform consists of processes, physical tumors and information that it uses to personalize the development and use of oncology drugs. Each tumor from patients that it has preserved for implantation in mice, along with the patient data and molecular information associated with the tumors, are known as TumorGrafts or Patient Derived XenoGrafts of PDX Models. The collection of TumorGrafts is referred to as the Company's TumorBank.
More

Webull offers Champions Oncology Inc (CSBR) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.